News

社会の激動

Nature Biotechnology 33, 1 doi: 10.1038/nbt.3106

The drug industry is struggling to find ways of engaging with consumers on social media. Failure to adapt may bring substantial opportunity costs, argues Virginia Hughes.

目次へ戻る

プライバシーマーク制度